EUVIMEDScopri EUVIMED
Open access · CC BY 4.0

Deuterium MRI of serine metabolism in mouse models of glioblastoma

Friederike Hesse iD, Jacob Low, Jianbo Cao, Flaviu Bulat, Felix Kreis iD, Alan J Wright, Kevin M Brindle iD

Magnetic Resonance in Medicine · 2024

DOI: 10.1002/mrm.30198 ↗

At a glance

Journal article in Magnetic Resonance in Medicine, 2024. Written by Friederike Hesse and 6 co-authors. Institution: Cancer Research UK Cambridge Institute, Cambridge, UK. Major MEDLINE topics: Glioblastoma, Serine, Brain Neoplasms, Deuterium. Cited 5 times so far (Crossref); 40 references. The full text is freely available (open access, CC BY 4.0). Funded by: Medical Research Council, Cancer Research UK.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Purpose

Serine is a major source of one‐carbon units needed for the synthesis of nucleotides and the production of intramitochondrial nicotinamide adenine dinucleotide phosphate (NADPH), and it plays an important role in cancer cell proliferation. The aim of this study was to develop a deuterium ( 2 H) MRS imaging method for imaging tumor serine metabolism.

Methods

Sequential ( 2 H) spectra and spectroscopic images were used to monitor the metabolism of [2,3,3‐ 2 H 3 ]serine in patient‐derived glioblastoma cells in vitro and in tumors obtained by their orthotopic implantation in mouse brain. Results [14,14‐ 2 H 2 ] 5,10‐methylene‐tetrahydrofolate, [ 2 H]glycine, [ 2 H]formate, and labeled water were detected in cell suspensions and water labeling in spectroscopic images of tumors. Studies in cells and tumors with variable mitochondrial content and inhibitor studies in cells demonstrated that most of the labeled serine was metabolized in the mitochondria. Water labeling in the cell suspensions was correlated with formate labeling; therefore, water labeling observed in tumors could be used to provide a surrogate measure of flux in the pathway of one‐carbon metabolism in vivo.

Conclusion

The method has the potential to be used clinically to select patients for treatment with inhibitors of one‐carbon metabolism and subsequently to detect their early responses to such treatment.

Subjects

MeSH terms (MEDLINE)

GlioblastomaSerineBrain NeoplasmsDeuteriumMagnetic Resonance ImagingAnimalsMiceHumansCell Line, TumorDisease Models, Animal

Author keywords

folate cycleone‐carbon metabolismserinetumor

Substances

SerineDeuterium

Authors and institutions

  • Cancer Research UK Cambridge Institute, Cambridge, UK.
  • Department of Radiology, University of Cambridge, Cambridge, UK.
  • Department of Chemistry, University of Cambridge, Cambridge, UK.
  • Department of Biochemistry, University of Cambridge, Cambridge, UK.

ORCID profiles: Friederike Hesse, Felix Kreis, Kevin M Brindle

Funding

  • Medical Research Council
  • Cancer Research UK

Cite

APA

Hesse, F., Low, J., Cao, J., Bulat, F., Kreis, F., Wright, A. J., & Brindle, K. M. (2024). Deuterium MRI of serine metabolism in mouse models of glioblastoma. Magnetic Resonance in Medicine. https://doi.org/10.1002/mrm.30198

Vancouver

Hesse F, Low J, Cao J, Bulat F, Kreis F, Wright AJ, et al. Deuterium MRI of serine metabolism in mouse models of glioblastoma. Magnetic Resonance in Medicine. 2024. doi:10.1002/mrm.30198

BibTeX
@article{Hesse2024,
  author = {Hesse, Friederike and Low, Jacob and Cao, Jianbo and Bulat, Flaviu and Kreis, Felix and Wright, Alan J and Brindle, Kevin M},
  title = {Deuterium MRI of serine metabolism in mouse models of glioblastoma},
  journal = {Magnetic Resonance in Medicine},
  year = {2024},
  doi = {10.1002/mrm.30198}
}
Start for free →